Inventor
LAWSON ALASTAIR DAVID GRIFFITHS
GB33 patents
⚠️ This page may combine multiple inventors who share the name “LAWSON ALASTAIR DAVID GRIFFITHS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UCB PHARMA SA
9 patentsUS9428570B2Aug 30, 2016
Antibody molecules having specificity for human OX40
UCB PHARMA SA18 citations90
US7993864B2Aug 9, 2011
Assay for identifying antibody producing cells
UCB PHARMA SA20 citations87
US7608694B2Oct 27, 2009
Antibody molecules having specificity for human IL-1β
UCB PHARMA SA8 citations84
US8986954B2Mar 24, 2015
DNA encoding function modifying Nav1.7 antibodies
UCB PHARMA SA6 citations82
US9394361B2Jul 19, 2016
Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13
UCB PHARMA SA4 citations70
US9034600B2May 19, 2015
DNA encoding antibody molecules which bind IL-17A and IL-17F
UCB PHARMA SA1 citations63
US7790414B2Sep 7, 2010
Methods for producing antibodies
UCB PHARMA SA2 citations62
US10048253B2Aug 14, 2018
Method for identifying compounds of therapeutic interest
UCB PHARMA SA0 citations51
US10017575B2Jul 10, 2018
Antibody molecules having specificity for human OX40
UCB PHARMA SA0 citations50
UCB BIOPHARMA SPRL
7 patentsUS10233243B2Mar 19, 2019
Anti-FcRn antibodies
UCB BIOPHARMA SPRL10 citations82
US9266953B2Feb 23, 2016
Methods of treating pain using function modifying NAv1.7 antibodies
UCB BIOPHARMA SPRL8 citations82
US9988446B2Jun 5, 2018
Methods of treatment using antibodies which bind IL-17A and IL-17F
UCB BIOPHARMA SPRL2 citations73
US11384148B2Jul 12, 2022
Anti-FcRn antibodies
UCB BIOPHARMA SPRL1 citations71
US9957320B2May 1, 2018
Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13
UCB BIOPHARMA SPRL3 citations70
US10112996B2Oct 30, 2018
Function modifying NAv1.7 antibodies
UCB BIOPHARMA SPRL0 citations51
US9738710B2Aug 22, 2017
Method of treating a patient for pain by administering an anti-ion channel antibody
UCB BIOPHARMA SPRL0 citations51
LAWSON ALASTAIR DAVID GRIFFITHS
5 patentsUS8614295B2Dec 24, 2013
Antibody molecules having specificity for human OX40
LAWSON ALASTAIR DAVID GRIFFITHS41 citations95
US8465744B2Jun 18, 2013
Method of treating inflammation by administering human IL-1B antibodies
LAWSON ALASTAIR DAVID GRIFFITHS4 citations62
US10479824B2Nov 19, 2019
Single chain FC polypeptides
LAWSON ALASTAIR DAVID GRIFFITHS1 citations58
US9394357B2Jul 19, 2016
Method for obtaining antibodies
LAWSON ALASTAIR DAVID GRIFFITHS1 citations51
US8304200B2Nov 6, 2012
Methods for obtaining antibodies
LAWSON ALASTAIR DAVID GRIFFITHS0 citations36
UCB Biopharma SRL
5 patentsUS11174311B2Nov 16, 2021
Antibody against trimeric TNFα complex
UCB Biopharma SRL4 citations72
US11919950B2Mar 5, 2024
Expression vector encoding antibody molecule which binds IL-17A and IL-17F
UCB Biopharma SRL0 citations62
US12338285B2Jun 24, 2025
Anti-FcRn antibodies
UCB Biopharma SRL0 citations60
US12327614B2Jun 10, 2025
Multi-domain proteins with increased native state colloidal stability
UCB Biopharma SRL0 citations55
US11942188B2Mar 26, 2024
Obtaining an improved therapeutic ligand
UCB Biopharma SRL0 citations52